dual glp 1 glucagon receptor agonists Survodutide GLP-1/Glucagon Agonist (BI 456906) Frontiers | GLP−1 receptor agonists

This can be achieved through dietary stimulants, pharmacological agents, or interventions targeting the gut microbiota

10.4093/dmj.2016.40.5.339 [DOI] [PMC free article] [PubMed] [Google Scholar] 17.Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al

These findings place GLP-1 receptor agonists among the most effective pharmacological strategies currently available for reducing cardiometabolic and renal risk in high-risk populations

For the first 16 weeks, it is taken in smaller doses, and if it is well tolerated, it can be increased to a weekly maintenance dose for as long as needed

doi: 10.1111/dom.14174

Consider eating smaller, more frequent meals to provide a steady stream of nutrients rather than experiencing energy peaks and crashes